Cargando…

Orphandev, French Clinical Trials Network dedicated to Orphan drugs and therapeutics development for rare diseases

Detalles Bibliográficos
Autores principales:	Adjibi, Yolande, Micallef, Joëlle, Blin, Olivier
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958400/ http://dx.doi.org/10.1186/1750-1172-5-S1-P11

Ejemplares similares

New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community
por: Hivert, Virginie, et al.
Publicado: (2010)

Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS)
por: Trieste, L, et al.
Publicado: (2015)

Go with the flow: de-orphaning focused combinatorial libraries
por: Reutlinger, Michael, et al.
Publicado: (2014)

Predictors of orphan drug approval
por: Heemstra, Harald
Publicado: (2010)

Evaluation of a patient-dedicated blood gas analyser
por: Fox, JJ, et al.
Publicado: (2015)

Safety data of Montanide ISA 51 VG and Montanide ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines
por: Ascarateil, Stephane, et al.
Publicado: (2015)

P-090: IS A DEDICATED MARKETING APPROVAL OF HYDROXYUREA IN SICKLE CELL DISEASE MAY INCREASE THE CLINICAL BENEFIT OF THE DRUG?
por: F., GALACTÉROS, et al.
Publicado: (2022)

Resrip: a network dedicated to children and adolescents suffering from chronic rheumatic diseases in the Ile-de-France region
por: Rossi-Semerano, Linda, et al.
Publicado: (2014)

Sustained release of actives with Montanide™ ISA 51 VG and Montanide™ ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines
por: Ascarateil, Stephane, et al.
Publicado: (2015)

Diagnostic algorithm for Primary Ciliary Dyskinesia: recommendations of the French National Centre for Rare Respiratory Diseases
por: Blanchon, S, et al.
Publicado: (2012)

Combatting the misuse of benzodiazepines and related Z drugs in French general practice: a clinical review
por: Gentile, Gaetan, et al.
Publicado: (2020)

Comparison of dedicated digital specimen radiography with direct digital specimen mammography images
por: Morel, JC, et al.
Publicado: (2011)

Target prediction by cascaded self-organizing maps for ligand de-orphaning and side-effect investigation
por: Reker, Daniel, et al.
Publicado: (2014)

Adhesion and colonization of mesenchymal stem cells on polylactide or PLCL fibers dedicated for tissue engineering
por: Balandras, Frédérique, et al.
Publicado: (2013)

Impact of a dedicated trauma desk in ambulance control on the identification of major trauma in Scotland
por: Bruce, J, et al.
Publicado: (2014)

The portal for rare diseases and orphan drugs
por: Singh, Jatinder
Publicado: (2013)

Social Preferences for Orphan Drugs: A Discrete Choice Experiment Among the French General Population
por: Toumi, Mondher, et al.
Publicado: (2020)

"Hands of fame": a new tool to improve dedication of key opinion leader for hand hygiene
por: Widmer, AF, et al.
Publicado: (2011)

Improvement in clinical outcomes following institution of dedicated critical care support in the high-dependency unit
por: Beckett, DJ, et al.
Publicado: (2009)

Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
por: Soeiro, Thomas, et al.
Publicado: (2021)

Reimbursement of orphan drugs: the Pompe and Fabry case in the Netherlands
por: van den Brink, Rinke
Publicado: (2014)

OrphanAnesthesia – anesthesia recommendations for patients suffering from rare diseases
por: Münster, Tino
Publicado: (2014)

Performance analysis of a dedicated breast MR-HIFU system during ablation of breast tumors in patients
por: Deckers, Roel, et al.
Publicado: (2015)

National results and 6 years trends of nosocomial infection surveillance in French intensive care units (REA-RAISIN network)
por: Savey, A, et al.
Publicado: (2015)

Central venous catheter-related infection: a cohort study evaluating dedicated central venous catheter packs
por: Mukerji, S, et al.
Publicado: (2009)

Initial experience with a dedicated cardiac MRI program for congenital heart disease in a limited resource environment
por: Kappanayil, Mahesh, et al.
Publicado: (2013)

Inter-observer variation in LV analysis in a dedicated CMR unit: the impact of audit and consensus guideline on reproducibility
por: Coulden, Richard, et al.
Publicado: (2014)

Sensitivity and specificity of a triage score dedicated to trauma patients in a tertiary-level hospital: preliminary results
por: Masturzo, P, et al.
Publicado: (2007)

Management of sepsis and septic shock in critically ill patients transferred by a dedicated transport team in the West of Scotland
por: Cadamy, A, et al.
Publicado: (2006)

Impact of a dedicated ventilatory support team on how mechanical ventilation is employed in a tertiary-care hospital
por: Saddy, F, et al.
Publicado: (2009)

Health technology assessment: oncology drugs with orphan designation as an example
por: Wild, Claudia
Publicado: (2010)

Rare diseases and orphan drugs: Latvian story
por: Logviss, Konstantins, et al.
Publicado: (2014)

Pricing of orphan drugs in oncology and rare diseases
por: Nuijten, Mark, et al.
Publicado: (2020)

Global assessment of performance of ICUs: a French experience
por: Faye, A, et al.
Publicado: (2008)

Management of stage 1 TTR FAP: French experience
por: Adams, David, et al.
Publicado: (2015)

ECCO(2)R, a french national survey
por: Deniau, B, et al.
Publicado: (2015)

Subacute and rehabilitation care facilities « Soins de Suite et de Réadaptation (SSR) », dedicated to HIV patients in Marseilles, France
por: Dimet, Jean-Paul, et al.
Publicado: (2010)

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database
por: Létinier, Louis, et al.
Publicado: (2021)

Therapeutic drug monitoring (TDM) of atazanavir in pregnancy
por: Else, LJ, et al.
Publicado: (2010)

French experience with rare diseases plans
por: Le Henanff, Guillaume, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_cvv40fl945lt7810j93uc16jm1